Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder cancer: tips and tricks for better efficacy and tolerability

被引：0
作者：
Abou Chakra, Mohamad [1 ]
Moussa, Mohamad [2 ]
O'Donnell, Michael A. [1 ]
机构：
[1] Univ IA, Dept Urol, Iowa City, IA 52242 USA
[2] Lebanese Univ, Al Zahraa Hosp, Dept Urol, Beirut, Lebanon
来源：
JOURNAL OF CHEMOTHERAPY | 2024年 / 36卷 / 08期
关键词：
RESCUE THERAPY; DOCETAXEL;
D O I：
10.1080/1120009X.2024.2325765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：694 / 697
页数：4
相关论文
共 38 条
  • [31] Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder Cancer: History and Current Status
    Liu, Gang
    Li, Bingheng
    Xu, Ziyang
    Wang, Jie
    Ma, Sai
    Kan, Yi
    Mao, Lijun
    DISCOVERY MEDICINE, 2022, 33 (169) : 85 - 92
  • [32] Emerging treatment options for bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
    Kokorovic, Andrea
    Ory, Jesse
    Saad, Fred
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (01) : 48 - 53
  • [33] A single-institution experience with induction and maintenance intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to bacille Calmette-Guerin therapy
    Barlow, LaMont
    McKiernan, James
    Sawczuk, Ihor
    Benson, Mitchell
    BJU INTERNATIONAL, 2009, 104 (08) : 1098 - 1102
  • [34] Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
    Ioannis Boukovinas
    Nikolaos Androulakis
    Nikolaos Kentepozidis
    Aris Polyzos
    Pavlos Papakotoulas
    Nikolaos Ziras
    Athanasios Kotsakis
    Nikolaos Vardakis
    Athanasios Karampeazis
    Vassilis Markos
    Athanasios Kostakopoulos
    Constantine A. Constantinides
    George Samonis
    Dimitris Mavroudis
    Vassilis Georgoulias
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 351 - 356
  • [35] Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
    Boukovinas, Ioannis
    Androulakis, Nikolaos
    Kentepozidis, Nikolaos
    Polyzos, Aris
    Papakotoulas, Pavlos
    Ziras, Nikolaos
    Kotsakis, Athanasios
    Vardakis, Nikolaos
    Karampeazis, Athanasios
    Markos, Vassilis
    Kostakopoulos, Athanasios
    Constantinides, Constantine A.
    Samonis, George
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 351 - 356
  • [36] Receptor-Targeting Drug and Drug Carrier for Enhanced Killing Efficacy against Non-Muscle-Invasive Bladder Cancer
    Mullapudi, Sneha Sree
    Zhang, Jing
    Lu, Shengjie
    Rahmat, Juwita Norasmara
    Mahendran, Ratha
    Kang, En-Tang
    Chiong, Edmund
    Neoh, Koon Gee
    ACS APPLIED BIO MATERIALS, 2019, 2 (09): : 3763 - 3773
  • [37] Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
    Boorjian, Stephen A.
    Alemozaffar, Mehrdad
    Konety, Badrinath R.
    Shore, Neal D.
    Gomella, Leonard G.
    Kamat, Ashish M.
    Bivalacqua, Trinity J.
    Montgomery, Jeffrey S.
    Lerner, Seth P.
    Busby, Joseph E.
    Poch, Michael
    Crispen, Paul L.
    Steinberg, Gary D.
    Schuckman, Anne K.
    Downs, Tracy M.
    Svatek, Robert S.
    Mashni, Joseph, Jr.
    Lane, Brian R.
    Guzzo, Thomas J.
    Bratslavsky, Gennady
    Karsh, Lawrence I.
    Woods, Michael E.
    Brown, Gordon
    Canter, Daniel
    Luchey, Adam
    Lotan, Yair
    Krupski, Tracey
    Inman, Brant A.
    Williams, Michael B.
    Cookson, Michael S.
    Keegan, Kirk A.
    Andriole, Gerald L., Jr.
    Sankin, Alexander I.
    Boyd, Alan
    O'Donnell, Michael A.
    Sawutz, David
    Philipson, Richard
    Coll, Ruth
    Narayan, Vikram M.
    Treasure, F. Peter
    Yla-Herttuala, Seppo
    Parker, Nigel R.
    Dinney, Colin P. N.
    LANCET ONCOLOGY, 2021, 22 (01) : 107 - 117
  • [38] Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non-muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guerin Therapy
    Robins, Dennis J.
    Sui, Wilson
    Matulay, Justin T.
    Ghandour, Rashed
    Anderson, Christopher B.
    DeCastro, G. Joel
    McKiernan, James M.
    UROLOGY, 2017, 103 : 149 - 153
1234